Original Research

Published on 23 Aug 2023

Differential impact of 5-lipoxygenase-activating protein antagonists on the biosynthesis of leukotrienes and of specialized pro-resolving mediators

in Inflammation Pharmacology

Philipp Dahlke
Lukas K. Peltner
Paul M. Jordan
Oliver Werz

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1219160

2,791 views
5 citations

Editorial

Published on 21 Aug 2023

Editorial: Autophagy in inflammation related diseases, volume II

in Inflammation Pharmacology

Bo-Zong Shao
Tian Xia
Elena Talero
Yu Bai

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1273511

1,010 views

Review

Published on 21 Aug 2023

Protein tyrosine phosphatase non-receptor type 2 as the therapeutic target of atherosclerotic diseases: past, present and future

in Inflammation Pharmacology

Xiao-Er Tang
Ya-Qiong Cheng
Chao-Ke Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1219690

3,210 views

Correction

Published on 17 Aug 2023

Corrigendum: Dauricine attenuates vascular endothelial inflammation through inhibiting NF-κB pathway

in Inflammation Pharmacology

Ji Hu
Ru Chen
Jie An
Yilong Wang
Minglu Liang
Kai Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1236892

1,310 views

Review

Published on 17 Aug 2023

Trinity of inflammation, innate immune cells and cross-talk of signalling pathways in tumour microenvironment

in Inflammation Pharmacology

Ali Attiq
Sheryar Afzal

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1255727

2,248 views
3 citations

Opinion

Published on 17 Aug 2023

Comments on “Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics”

in Inflammation Pharmacology

Yazan Ranneh
Ayman M. Mahmoud
Abdulmannan Fadel
Mohd Fadzelly Abu Bakar
Abdah Md Akim

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1228359

1,069 views

Original Research

Published on 15 Aug 2023

Aminooxy acetic acid suppresses Th17-mediated psoriasis-like skin inflammation by inhibiting serine metabolism

in Inflammation Pharmacology

Jong Yeong Lee
Ji-Hyun Lee
Hyo Jung Lim
Eonho Kim
Dae-Ki Kim
Jin Kyeong Choi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1215861

2,485 views
4 citations

Original Research

Published on 15 Aug 2023

Identification of polyunsaturated fatty acids as potential biomarkers of osteoarthritis after sodium hyaluronate and mesenchymal stem cell treatment through metabolomics

in Inflammation Pharmacology

Qinyan Yang
Yiran Zhao
Na Li
Jian-Lin Wu
Xiaolun Huang
Mei Zhang
Xiqing Bian
Yi-Zhun Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1224239

2,528 views
1 citation

Review

Published on 11 Aug 2023

Therapeutic potential of Coptis chinensis for arthritis with underlying mechanisms

in Inflammation Pharmacology

Mengyuan Li
Fei Tian
Jinling Guo
Xiankuan Li
Lin Ma
Miaomiao Jiang
Jing Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1243820

4,361 views
6 citations

Systematic Review

Published on 08 Aug 2023

Risk of herpes zoster associated with JAK inhibitors in immune-mediated inflammatory diseases: a systematic review and network meta-analysis

in Inflammation Pharmacology

Qingling Xu
Liyuan He
Yufeng Yin

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1241954

7,576 views
19 citations

Mini Review

Published on 04 Aug 2023

New advances in clinical application of neostigmine: no longer focusing solely on increasing skeletal muscle strength

in Inflammation Pharmacology

Shangkun Si
Xiaohu Zhao
Fan Su
Hongxiu Lu
Dongbin Zhang
Li Sun
Fulei Wang
Li Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1227496

5,349 views
2 citations

Original Research

Published on 02 Aug 2023

As an inhibitor of norepinephrine release, dexmedetomidine provides no improvement on stroke-associated pneumonia in mice

in Inflammation Pharmacology

Miaomiao Zhou
Qiong Luo
Younian Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1203646

1,916 views

Review

Published on 01 Aug 2023

The applications of functional materials-based nano-formulations in the prevention, diagnosis and treatment of chronic inflammation-related diseases

in Inflammation Pharmacology

Jingjing Wang
Rui Ni
Tingting Jiang
Dan Peng
Yue Ming
Hongjuan Cui
Yao Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1222642

2,443 views

Original Research

Published on 01 Aug 2023

Salvianolic acid B attenuates inflammation and prevent pathologic fibrosis by inhibiting CD36-mediated activation of the PI3K-Akt signaling pathway in frozen shoulder

in Inflammation Pharmacology

Yan Yan
Min Zhou
Ke Meng
Chuanhai Zhou
Xiaoyu Jia
Xinhao Li
Dedong Cui
Menglei Yu
Yiyong Tang
Ming Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1230174

2,947 views
7 citations

Original Research

Published on 28 Jul 2023

Apolipoprotein A-I attenuates peritoneal fibrosis associated with peritoneal dialysis by inhibiting oxidative stress and inflammation

in Inflammation Pharmacology

Jing Lu
Jie Gao
Jing Sun
Haiping Wang
Huijuan Sun
Qian Huang
Yao Zhang
Shuo Zhong

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1106339

2,180 views
6 citations

Review

Published on 27 Jul 2023

Immunometabolism changes in fibrosis: from mechanisms to therapeutic strategies

in Inflammation Pharmacology

Lixiang Feng
Xingyu Chen
Yujing Huang
Xiaodian Zhang
Shaojiang Zheng
Na Xie

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1243675

3,266 views
2 citations

Navigation group

Articles

Differential impact of 5-lipoxygenase-activating protein antagonists on the biosynthesis of leukotrienes and of specialized pro-resolving mediators

Editorial: Autophagy in inflammation related diseases, volume II

Protein tyrosine phosphatase non-receptor type 2 as the therapeutic target of atherosclerotic diseases: past, present and future

Corrigendum: Dauricine attenuates vascular endothelial inflammation through inhibiting NF-κB pathway

Trinity of inflammation, innate immune cells and cross-talk of signalling pathways in tumour microenvironment

Comments on “Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics”

Aminooxy acetic acid suppresses Th17-mediated psoriasis-like skin inflammation by inhibiting serine metabolism

Identification of polyunsaturated fatty acids as potential biomarkers of osteoarthritis after sodium hyaluronate and mesenchymal stem cell treatment through metabolomics

Therapeutic potential of Coptis chinensis for arthritis with underlying mechanisms

Risk of herpes zoster associated with JAK inhibitors in immune-mediated inflammatory diseases: a systematic review and network meta-analysis

New advances in clinical application of neostigmine: no longer focusing solely on increasing skeletal muscle strength

As an inhibitor of norepinephrine release, dexmedetomidine provides no improvement on stroke-associated pneumonia in mice

The applications of functional materials-based nano-formulations in the prevention, diagnosis and treatment of chronic inflammation-related diseases

Salvianolic acid B attenuates inflammation and prevent pathologic fibrosis by inhibiting CD36-mediated activation of the PI3K-Akt signaling pathway in frozen shoulder

Apolipoprotein A-I attenuates peritoneal fibrosis associated with peritoneal dialysis by inhibiting oxidative stress and inflammation

Immunometabolism changes in fibrosis: from mechanisms to therapeutic strategies